+20.1%
GSK vs PODD
-60.9%
+81.1%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PODD | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -2.0% | +2.0% | +0.2% |
| 7D | -3.5% | -10.5% | +7.0% | -2.5% |
| 30D | -3.4% | -9.0% | +5.6% | -2.6% |
| 3M | -8.1% | -11.5% | +3.4% | -7.4% |
| 6M | -11.1% | -44.7% | +33.6% | -8.9% |
| YTD | +0.7% | -53.6% | +54.3% | +2.8% |
| 1Y | +20.1% | -61.0% | +81.1% | +20.4% |
| All | +20.1% | -60.9% | +81.1% | +20.4% |
Cumulative growth
Daily Returns
Daily percentage return beside PODD.
Daily Out/Under-Performance
Portfolio return minus PODD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PODD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PODD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling